Skip to content
2000
Volume 21, Issue 10
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

With the acceleration of people's pace of life, non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in the world, which greatly threatens people's health and safety. Therefore, there is still an urgent need for higher-quality research and treatment in this area. Nuclear factor Red-2-related factor 2 (Nrf2), as a key transcription factor in the regulation of oxidative stress, plays an important role in inducing the body's antioxidant response. Although there are no approved drugs targeting Nrf2 to treat NAFLD so far, it is still of great significance to target Nrf2 to alleviate NAFLD. In recent years, studies have reported that many natural products treat NAFLD by acting on Nrf2 or Nrf2 pathways. This article reviews the role of Nrf2 in the pathogenesis of NAFLD and summarizes the currently reported natural products targeting Nrf2 or Nrf2 pathway for the treatment of NAFLD, which provides new ideas for the development of new NAFLD-related drugs.

Loading

Article metrics loading...

/content/journals/cdd/10.2174/0115672018260113231023064614
2024-12-01
2025-05-03
Loading full text...

Full text loading...

/content/journals/cdd/10.2174/0115672018260113231023064614
Loading

  • Article Type:
    Review Article
Keyword(s): FFA; inflammation; NAFLD; natural regulators; Nrf2; TG
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test